Cancer Research UK logo.
SearchDonate
  • Search

A trial of capivasertib for triple negative breast cancer (CAPItello 290)

Overview

Cancer types:

Breast cancer, Secondary cancers

Status:

Closed

Phase:

Phase 3

Details

This trial is for people with triple negative breast cancer that has come back or spread to another part of the body.

Triple negative breast cancers are cancers without for:

Recruitment start: 1 July 2019

Recruitment end: 21 December 2021

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Prof Peter Schmid

Supported by

AstraZeneca AB

Last reviewed: 20 January 2022

CRUK internal database number: 16689

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.